Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The GH–IGF‐I axis and the cardiovascular system: clinical implications

Open access
Colao, Annamaria · 2008 · Clinical Endocrinology

Abstract

Summary: Background GH and IGF‐I affect cardiac structure and performance. In the general population, low IGF‐I has been associated with higher prevalence of ischaemic heart disease and mortality. Both in GH deficiency (GHD) and excess life expectancy has been reported to be reduced because of cardiovascular disease. Objective To review the role of the GH–IGF‐I system on the cardiovascular system. Results Recent epidemiological evidence suggests that serum IGF‐I levels in the low‐normal range are associated with increased risk of acute myocardial infarction, ischaemic heart disease, coronary and carotid artery atherosclerosis and stroke. This confirms previous findings in patients with acromegaly or with GH‐deficiency showing cardiovascular impairment. Patients with either childhood‐ or adulthood‐onset GHD have cardiovascular abnormalities such as reduced cardiac mass, diastolic filling and left ventricular response at peak exercise, increased intima‐media thickness and endothelial dysfunction. These abnormalities can be reversed, at least partially, after GH replacement therapy. In contrast, in acromegaly chronic GH and IGF‐I excess causes a specific cardiomyopathy: concentric cardiac hypertrophy (in more than two‐thirds of the patients at diagnosis) associated to diastolic dysfunction is the most common finding. In later stages, impaired systolic function ending in heart failure can occur, if GH/IGF‐I excess is not controlled. Abnormalities of cardiac rhythm and of cardiac valves can also occur. Successful control of acromegaly is accompanied by decrease of the left ventricular mass and improvement of cardiac function. Conclusion The cardiovascular system is a target organ for GH and IGF‐I. Subtle dysfunction in the GH–IGF‐I axis are correlated with increased prevalence of ischaemic heart disease. Acromegaly and GHD are associated with several abnormalities of the cardiovascular system and control of GH/IGF‐I secretion reverses (or at least stops) cardiovascular abnormalities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03292.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 209

Metadata

Authors
Colao, A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2008-08-13
Volume
69
Issue
3
Pages
347-358
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2014798423
Cited by
209
References
6
FWCI
12.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The GH–IGF‐I axis and the cardiovascular system: clinical implications. https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03292.x
The paper
Colao, A. (2008). The GH–IGF‐I axis and the cardiovascular system: clinical implications. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03292.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.